v3-fanout-d-26 — Workgraph

Metadata

Status	done
Assigned	`agent-62`
Agent identity	`3184716484e6f0ea08bb13539daf07686ee79d440505f1fdf2de0357707034c3`
Created	2026-05-01T20:43:59.506529020+00:00
Started	2026-05-01T20:52:20.036444584+00:00
Completed	2026-05-01T20:56:22.739301956+00:00
Tags	`grant,urgent,v3,fanout`, `eval-scheduled`
Eval score	0.92
└ blocking impact	0.95
└ completeness	0.90
└ constraint fidelity	0.70
└ coordination overhead	0.90
└ correctness	0.95
└ downstream usability	0.90
└ efficiency	0.85
└ intent fidelity	0.92
└ style adherence	0.95

Description

Fanout drafter D. Refits team / track record (§26) to the v3 spine. The track record narrative shifts from 'we did PHR work' to 'we build foundational genomics infrastructure (references, analysis tools, AI orchestration) and have a track record of reliable, widely-adopted open-source delivery.'

What to read

~/poietic.life/notes/v3-spine-brief.md
workgraph_google_application_FINAL_v2.md — current §26 and §27 (team bios)
CLAUDE.md — co-founder bios, attribution rules (no C.Origami/Chromnitron to Luca; CRISPRme/Casgevy framing precise)

What to write

Output: ~/poietic.life/notes/v3-sections/v3-section-26.md

Section §26 has a 150-word cap. Recount.

The narrative thread to weave:

Erik: vg (72k+ Scholar citations, foundational pangenomics toolkit), PGGB (used by HPRC for the human pangenome reference, Nature Methods 2024). Builds reference resources that the entire genomics community depends on. NSF PPoSS LARGE PI (M) for computational pangenomics.
Luca: CRISPResso2 (18,700+ citations, standard for CRISPR analysis), CRISPRme (independent off-target finding informed FDA review of Casgevy — frame precisely per CLAUDE.md, Canver 2015 contributed to BCL11A enhancer strategy that became Casgevy + CRISPRme 2023 independently identified an off-target). Chorus orchestrates genomic AI including AlphaGenome. IGVF Consortium characterization center lead.
Vaughn: organizational design under uncertainty (Columbia book, ASQ paper, Harvard PhD). Honorary Professor UCL. Former Google. FLF / Ethereum Foundation / Singapore CSF fellow.

Through-line: each founder has a track record of reliable, widely-adopted, open-source-ish delivery in their domain. The team's authority is verifiable, not claimed.

If §27 (team bios full version) needs adjustment, also include those revisions in the same output file under a clear ### §27 heading. CLAUDE.md says §27 may not have a strict word cap but check v2 to see what it currently uses.

Constraints

§26 ≤150 words. Recount.
§27 (if revised) preserves its v2 word usage.
No em-dashes. No PI. Founder order Erik / Luca / Vaughn.
Do NOT attribute C.Origami or Chromnitron to Luca.
CRISPRme/Casgevy framing factually precise — do not say 'CRISPRme provided off-target analysis for the BCL11A guide used in Casgevy.'
No specific effort percentages.
Output as markdown.

Validation

§26 ≤150 words
All three founders represented; Erik first
Reference-resource track record (vg, PGGB, HPRC) explicitly cited for Erik
CRISPResso/CRISPRme cited for Luca with precise Casgevy framing
Vaughn's organizational design track record cited
No PI language, no effort percentages
Output at ~/poietic.life/notes/v3-sections/v3-section-26.md

## Description

Fanout drafter D. Refits team / track record (§26) to the v3 spine. The track record narrative shifts from 'we did PHR work' to 'we build foundational genomics infrastructure (references, analysis tools, AI orchestration) and have a track record of reliable, widely-adopted open-source delivery.'

## What to read
1. `~/poietic.life/notes/v3-spine-brief.md`
2. `workgraph_google_application_FINAL_v2.md` — current §26 and §27 (team bios)
3. `CLAUDE.md` — co-founder bios, attribution rules (no C.Origami/Chromnitron to Luca; CRISPRme/Casgevy framing precise)

## What to write

Output: `~/poietic.life/notes/v3-sections/v3-section-26.md`

Section §26 has a 150-word cap. Recount.

The narrative thread to weave:
- Erik: vg (72k+ Scholar citations, foundational pangenomics toolkit), PGGB (used by HPRC for the human pangenome reference, Nature Methods 2024). Builds reference resources that the entire genomics community depends on. NSF PPoSS LARGE PI (M) for computational pangenomics.
- Luca: CRISPResso2 (18,700+ citations, standard for CRISPR analysis), CRISPRme (independent off-target finding informed FDA review of Casgevy — frame precisely per CLAUDE.md, Canver 2015 contributed to BCL11A enhancer strategy that became Casgevy + CRISPRme 2023 independently identified an off-target). Chorus orchestrates genomic AI including AlphaGenome. IGVF Consortium characterization center lead.
- Vaughn: organizational design under uncertainty (Columbia book, ASQ paper, Harvard PhD). Honorary Professor UCL. Former Google. FLF / Ethereum Foundation / Singapore CSF fellow.

Through-line: each founder has a track record of reliable, widely-adopted, open-source-ish delivery in their domain. The team's authority is verifiable, not claimed.

If §27 (team bios full version) needs adjustment, also include those revisions in the same output file under a clear `### §27` heading. CLAUDE.md says §27 may not have a strict word cap but check v2 to see what it currently uses.

## Constraints
- §26 ≤150 words. Recount.
- §27 (if revised) preserves its v2 word usage.
- No em-dashes. No PI. Founder order Erik / Luca / Vaughn.
- Do NOT attribute C.Origami or Chromnitron to Luca.
- CRISPRme/Casgevy framing factually precise — do not say 'CRISPRme provided off-target analysis for the BCL11A guide used in Casgevy.'
- No specific effort percentages.
- Output as markdown.

## Validation
- [ ] §26 ≤150 words
- [ ] All three founders represented; Erik first
- [ ] Reference-resource track record (vg, PGGB, HPRC) explicitly cited for Erik
- [ ] CRISPResso/CRISPRme cited for Luca with precise Casgevy framing
- [ ] Vaughn's organizational design track record cited
- [ ] No PI language, no effort percentages
- [ ] Output at `~/poietic.life/notes/v3-sections/v3-section-26.md`

Depends on

Required by

Log

2026-05-01T20:43:59.505546848+00:00 Task paused
2026-05-01T20:44:51.888975139+00:00 Task published
2026-05-01T20:52:20.036447850+00:00 Spawned by coordinator --executor claude --model opus
2026-05-01T20:52:31.068447308+00:00 Starting v3 fanout D — refitting §26 (and §27 if needed) to v3 spine; reading brief, v2 application, CLAUDE.md attribution rules
2026-05-01T20:56:02.170560766+00:00 Drafted §26 (150/150 words). All three founders represented, Erik first. Garrison: vg + PGGB + HPRC + NSF PPoSS LARGE. Pinello: CRISPResso2 + CRISPRme/Casgevy with precise Canver-2015 framing + Chorus/AlphaGenome + IGVF. Tan: Harvard PhD, ASQ 2015, Columbia 2020, UCL, ex-Google, FLF/Ethereum/Singapore CSF. Closing through-line 'authority is verifiable, not claimed'. No PI language, no em-dashes, no effort percentages, no C.Origami/Chromnitron.
2026-05-01T20:56:02.187507953+00:00 §27 in v2 is just AI Maturity category answer (AI First); flagged in output that no revision is needed for §27 and that the team narrative paragraph (§30) is a separate fanout's responsibility — not redrafting it here.
2026-05-01T20:56:16.977723172+00:00 Committed ce9f876 to poietic.life main, pushed. Validated all checklist items: §26=150 words, all three founders present + Erik first, vg/PGGB/HPRC cited for Erik, CRISPResso2/CRISPRme cited for Luca with precise Casgevy framing (Canver 2015 + independent CRISPRme finding informing FDA review, no implied direct collaboration), Vaughn org-design track record cited (Harvard PhD, ASQ 2015, Columbia Press 2020), no PI language, no effort percentages, output at ~/poietic.life/notes/v3-sections/v3-section-26.md.
2026-05-01T20:56:22.739309841+00:00 Task pending eval (agent reported done; awaiting `.evaluate-*` to score)
2026-05-01T20:58:51.859347259+00:00 PendingEval → Done (evaluator passed; downstream unblocks)